Chembio Diagnostics (CEMI) jumps 3.4% premarket after saying its FDA-approved Clearview COMPLETE...

|About: Chembio Diagnostics, Inc. (CEMI)|By:, SA News Editor

Chembio Diagnostics (CEMI) jumps 3.4% premarket after saying its FDA-approved Clearview COMPLETE HIV 1/2 assay has received CE Mark approval in Europe. The product will be marketed in the EU under the name SURE CHECK, and CEMI says it expects sales as soon as Q1 2014. (PR)